Category
»
Primary study
Registry of Trials»Brazilian Registry of Clinical Trials
Year
»
2018
Links
»
INTERVENTION: E02.760.169.063.500.387 G11.427.590.530.698.277 Method used was the Tai‐Geiko which is a differentiated physical activity, held in group of people through basic and complex daily movements, for the purpose of exercising various areas of the body. For this was used enclosed, quiet, airy, disturbing, well‐lit and air‐conditioned environment with enough space. In addition, it was necessary a mat for each participant, a stereo, an aluminum stick and a bottle of eucalyptus essence. Tai‐Geiko is a technique of exercises peculiar to stimulate physical and mental aspects of its followers. Experimental study, with 19 participants allocated to two groups: experimental group (NS) (n = 10) practiced twice a week with a duration of 1 hour in the 8 week period and placebo group (CG) (n = 09). The following were evaluated before and after the protocol, with the expanded scale of the disability state (EDSS ‐ maximum score of 6.0), force test (kg / f) per manual dynamometer, scapular and lumbar, mobility test by Time Up and Go (TUG), motor and cognitive function by the dual task test and the stabilometric equilibrium test (EMG platform system. Placebo group: did not do the proposed exercise, but continued with the normal routine of physical therapy treatment. Experimental group: they did 24 exercise sessions, lasting 60 minutes each. The frequency: two weekly sessions at predetermined times and 75% presence. Exercises were composed of four parts: 1st heating and stretching, with approximately 10 minutes of duration; 2nd motor‐physical content with approximately 20 minutes duration; 3rd content Sensory‐cognitive, with approximately 20 minutes duration; 3rd relaxation, approximately 10 minutes long. Note: In the heating and stretching part, repeated and cyclic physical exertions were performed with the purpose of increasing the temperature of the locomotor apparatus followed by muscle stretching exercises of the groups that will be most requested in the respective session. In order to compose the CONDITION: C10.114.375.500 C10.114.375.500.200 C10.114.375.500.600 Tracked people with multiple sclerosis and perform intervention with goal of preventing problems of muscle weakness and improvement of the decrease of balance. Immune System Diseases, Multiple Sclerosis, Progressive Chronic Multiple Sclerosis, Multiple Sclerosis Relapsing‐Sender. ; C10.114.375.500 ; C10.114.375.500.200 ; C10.114.375.500.600 PRIMARY OUTCOME: As it is a rare pathology was worked with the amount of people registered in the Association of people with sclerosis Cuiabá and who accepted to participate or who were not in the wheelchair or bedridden.; ; 1) Expected outcome; ; It was evaluated the differences in physical and balance aspects in patients with multiple sclerosis practitioners of Tai‐Geiko and sedentary.; Expected Outcomes; Trajectory traversed (expected to decrease in the experimental group and maintain in the control group); Anteroposterior amplitude (cop) (expected to decrease in the experimental group and maintain in the control group); Medium‐lateral amplitude (ml) (expected to decrease in the experimental group and increase in the control group); Elliptical area (expected to decrease in the experimental group and maintain in the control group); Median anteroposterior frequency (expected to increase in the experimental group and decrease in the control group); Median‐lateral medial frequency (expected to increase in the experimental group and decrease in the control group); It was expected that the experimental group and control did not present improvement of scapular, lumbar and manual muscle strength.; The experimental group was expected to improve agility in lifting, walking and sitting.; The experimental group was expected to improve the performance of two tasks at the same time (double task); The experimental group was expected to show improvement in walking speed; ; ; ; 2) Methods used to evaluate primary outcome; ; Power Platform; Scapular dynamometer; Lumbar Dynamometer; Hand Dynamometer; Test Time up and go‐ TUG; Double task test; Walking speed; ; 3) Presentation of parameters; ; Reduction of the trajectory traversed through the force platform method from the variation of at least 6% in the pre and post intervention measurements (above 35cm high risk of fall).; ; Decreased anteroposterior amplitude by the force platform method from the variation of at least 2% in the pre and post intervention measurements (above 10 cm high risk of falling).; ; Decreased lateral mean amplitude through the force platform method from the variation of at least 2% in the pre and post intervention measurements (above 3cm high risk of falling).; ; Decreased elliptic area using the force platform method from the variation of at least 15% in pre and post intervention measurements (below 60 cm high risk of fall).; ; Decreased mid‐anteroposterior frequency using the force platform method from a variation of at least 5% in pre and post intervention measurements (below 1.4 Hz, a high risk of falls).; ; Decrease of the median mean lateral frequency through the force platform method from the variation of at least 5% in the pre and post intervention measurements (below 1.4 Hz).; ; Maintenance of the scapular muscle strength assessed by the scapular dynamometer from the variation of at least 5% in the pre and post intervention measurements (three measurements were performed and a mean was made and compared in the first and second moment reference value 27.2 Kgf both sexes).; ; Maintenance of the lumbar muscle strength assessed by the lumbar dynamometer from the variation of at least 18% in the pre and post intervention measurements (three measurements were performed and a mean was made and compared in the first and second moment reference value 114.0 kgf for men and 48.5 Kgf for women).; ; ; Maintenance of manual muscle strength assessed by the manual dynamometer from the variation of at least 10% in the pre and post intervention measurements (three measurements were performed and a mean was made and compared in the first and second moment reference value 40.5 Kgf for men and 28.4 Kgf for women).; ; ; Improved agility in the stand up, walk and sit evaluated using the Time up and go test from the variation of at least 1% in the pre and post intervention measurements (it was timed and calculated in minutes, performed 3 times and averaged of the three measurements up to 10 'normal, 10' to 20 'normal for elderly and with multiple sclerosis, 21' to 29 'risk of moderate fall and 30' high risk of falling).; ; Improvement of the performance of two tasks at the same time evaluated through the double task test from the variation of at least 29% in the pre‐ and post‐intervention measurements (it was performed twice and timed in seconds, where negative values ??indicate that the performance worsened in the double task in relation to the isolated task, and positive values ??may indicate a relative improvement in performance with the double task).; ; ; Improvement of the walking speed evaluated by the walk velocity test from the variation of at least 83% in the pre and post intervention measurements (calculated in seconds was timed and calculated in minutes, was performed 3 times and the mean of the three measurements was done until 10 'normal, 10' to 20 'normal for elderly and with multiple sclerosis, 21' to 29 'risk of moderate fall and 30' high risk of falls). Outcome finding (GE experimental group / GC control group); ; ; ; ‐ Trajectory traversed raise GE 38.24 to 26.64 / GC 32.01 to 38.88; ‐Traced path sit GE 45.19 to 29.84 / GC 32.16 to 31.19; ‐ Anteroposterior range (cop) raise GE 11.35 to 8.76 / GC 10.45 to 9.66; ‐Applitude anteroposterior (cop) sit GE12.40 to 9.94 / GC 11.84 to 9.53; ‐Average range (ml) raise GE 3.38 to 3.2 / GC 4.96 to 5.99; ‐Average medial‐lateral (ml) sit GE 4.17 to 3.47 / GC 5.48 to 5.01; ‐Elliptical area lift GE 35.95 to 36.7 / GC 68.85 to 62.10; ‐ Elliptical area sit GE 56.92 for 42.36 / GC 70.13 for 55.48; ‐Frequency median anteroposterior raise GE 1.0 to 1.56 / GC 1.66 to 1.3; ‐Frequency median anteroposterior lay GE 0.8 to 1.25 / GC 1.35 to 1.22; ; ‐Frequency median‐lateral raise GE 1.30 to 1.71 / GC 1.47 to 1.59; ‐Frequency median‐lateral sit GE 1.31 to 1.53 / GC 1.88 to 1.62; ; ‐GPS scapular strength 9.55 to 9.52 / GC 10.45 to 11.27 (experimental group maintained strength and control group increased); ‐ Lumbar muscle strength GE 37.65 to 51.95 / GC 53.1 to 58.14 (both experimental and control groups increased strength); ‐ Right manual muscle strength GE 26.63 to 30.5 / GC 25.9 to 28.83, left hand force GE 25.95 to 28.73 / GC 24.7 to 26.13 (the two experimental and control groups increased strength); ‐Agility in raising, walking and sitting activity (both experimental and control groups improved agility) GE 11.15 seconds to 9.35 / GC 9.89 to 8.70; ‐Two tasks at the same time GE 55.5 to 43.91 / GC 40.56 to 43.91 (experimental group improved the time spent to perform the dual task and the control group increased the time spent to perform the dual task); GE walking speed 5 minutes and 19 seconds to 3 minutes and 55 seconds / GC 4 minutes and 55 seconds to 4 minutes and 54 seconds. (the experimental group improved the time spent on walking and the control group kept the time spent on the test) SECONDARY OUTCOME: Secondary outcome was not expected INCLUSION CRITERIA: Medical diagnosis of multiple sclerosis for two years; Undergoing treatment with medical follow‐up; Obtain Expanded Disability Status Scale EDSS score of less than 6.0; Do not have medical diagnosis of diseases secondary to Multiple Sclerosis as: physical and / or mental deficiencies; heart diseases; Dyslipidemias; And Diabetes Mellitus;
Epistemonikos ID: e4ed67a51d2037350497902fd7f6be1a0aa3dbed
First added on: Aug 24, 2024